- STAT+: NIAID appoints new acting director after weekslong questions over leadershipThe NIH has appointed researcher John Powers III to lead its infectious disease institute on an acting basis, after weeks of being in leadership limbo.STAT · 1mo ago↗ source
- STAT+: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and moreGSK agreed to buy Nuvalent, a cancer drug developer, in a deal worth $10.6 billion, as the company continues its expansion in oncologySTAT · 1mo ago↗ source
- Dexcom RCT suggests CGM benefits for broad diabetes populationIn this edition of STAT Health Tech: Dexcom's CGM trial, udpates from Apple's annual developers' conference, and wearables.STAT